Reclassification of medicines: LAMISIL AT 1 per cent SPRAY and CREAM

Home > Notice-board > Reclassification > Lamisil AT 1 per cent spray and cream

Lamisil AT 1 per cent spray and cream

Novartis Consumer Health has appled to the to the Medicines and Healthcare products Regulatory Agency to have Lamisil AT 1 per cent spray (terbinafibe hydrochloride) reclassified as general sale list medicine.

Consultation period: 15 October 2003 to 26 November 2003.

ARM16: Request to reclassify Lamisil AT 1% Spray and Lamisil AT Cream from P to GSL (Microsoft Word document)

Reclassification
P to GSL

Status
Completed